Stock listing
OTC:ACHFF Arch Biopartners, Inc. Stock
US listing (OTC) of Arch Biopartners, Inc. · home listing TSXV:ARCH
Follow Arch Biopartners, Inc. into a list and get an email when it puts out news.
Share price · OTC:ACHFF
$0.595 USD 0.000 (0.0%)
Close on Oct 27, 2026
- Day range
- $0.595 – $0.595 USDOct 27, 2026
- Market cap
- $40.42M USDAt the close on Oct 27, 2026 · price × 67.93M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSXV:ARCH · Home | $0.79 CAD | -0.04 (-4.8%) | 8,546 | $0.82 | $0.83 | $0.79 | $0.83 | Close on Nov 2, 2026 |
| OTC:ACHFF | $0.595 USD | 0.000 (0.0%) | — | $0.595 | $0.595 | $0.595 | $0.595 | Close on Oct 27, 2026 |
- Ticker
- OTC:ACHFF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Aug 31, 2026
Arch Biopartners Receives Central IRB Approval to Support U.S. Sites in Phase II Cardiac Surgery-Associated Acute Kidney Injury Trial of LSALT Peptide
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 28 slides
Latest news
Decks
Investor Presentation (October 2026)
Investor deck · 28 slides · October 2026
Investor Presentation (September 2026)
Investor deck · 28 slides · September 2026
Investor Presentation (August 2026)
Investor deck · 28 slides · August 2026
Investor Presentation (July 2026)
Investor deck · 28 slides · July 2026
Arch Biopartners, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 24 in all · newest Aug 31, 2026 · oldest 2009
- Decks
- 23 decks · latest October 2026
Where Arch Biopartners, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:ARCH · Home listing | TSXV | Canada | CAD |
| Cboe Canada:ARCH | Cboe Canada | Canada | CAD |
| OTC:ACHFF · This page | OTC | United States | USD |
| Frankfurt:8HA | Frankfurt | Germany | EUR |
Log in to ask 6ix AI your own questions about Arch Biopartners, Inc.